Compare TRXB & FINS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | TRXB | FINS |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 388.6M | 418.0M |
| IPO Year | 2026 | 2018 |
| Metric | TRXB | FINS |
|---|---|---|
| Price | $14.88 | $11.88 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | N/A | ★ 49.3K |
| Earning Date | 11-12-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | N/A | $11.83 |
| 52 Week High | N/A | $13.45 |
| Indicator | TRXB | FINS |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 42.11 |
| Support Level | N/A | $11.83 |
| Resistance Level | N/A | $13.04 |
| Average True Range (ATR) | 0.00 | 0.15 |
| MACD | 0.00 | 0.03 |
| Stochastic Oscillator | 0.00 | 22.08 |
Angel Oak Financial Strats Income Term Trust is a non-diversified, closed-end management investment company. The fund's objective is to seek current income with a secondary objective of total return. In pursuing its investment objective, the fund invests mainly in debt issued by financial institutions, including subordinated debt, unrated debt, senior debt, and high-yield securities.